Cannabinoid receptor agonist‐stimulated [35S]guanosine triphosphateγs binding in the brain of C57BL/6 and DBA/2 mice
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The two inbred strains of mice C57BL/6 (alcohol‐preferring) and DBA/2 (alcohol‐avoiding) mice have been shown to differ significantly in their preference for alcohol (EtOH). We have previously demonstrated the differences in the density and the affinity of cannabinoid (CB1) receptors in the brains of the two inbred C57BL/6 and DBA/2 mouse strains. In the present study, we investigated the CB1 receptor agonist‐stimulated guanosine‐5′‐O‐(3‐[35 S]thio)‐triphosphate ([35 S]GTPγS) binding in plasma membranes (PM) from C57BL/6 and DBA/2 mice. The results indicate that the net CP55,940‐stimulated [35 S]GTPγS binding was increased with increasing concentrations of CB1 receptor agonists and GDP. The net CB1 receptor agonist (WIN55,212‐2 or HU‐210 or CP55,940)‐stimulated [35 S]GTPγS binding was reduced significantly (–10% to –12%, P < 0.05) in PM from DBA/2 mice; no significant differences were observed in basal [35 S]GTPγS binding among these strains. Nonlinear regression analysis of net CP55,940‐stimulated [35 S]GTPγS binding showed that the B max of cannabinoid agonist‐stimulated binding was significantly reduced (–24%) in DBA/2 mice (B max = 12.43 ± 0.64 for C57BL/6 and 9.46 ± 0.98 pmol/mg protein for DBA/2; P < 0.05) without any significant changes in the G protein affinity. The pharmacological specificity of CP55,940‐stimulated [35 S]GTPγS binding was examined with CB1 receptor antagonist SR141716A, and these studies indicated that CP55,940‐stimulated [35 S]GTPγS binding was blocked by SR141716A, with a decrease in the IC 50 values in the PM from the DBA/2 mouse strain. These results suggest that a signal transduction pathway(s) downstream from the CB1 receptor system may play an important role in controlling the voluntary EtOH consumption by these strains of mice. J. Neurosci. Res. 64:429–436, 2001. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 1×
“CB1 receptors in the brain are more numerous than other G protein-coupled receptors and are localized in most brain regions, including the hippocampus, cortex, caudateputamen, globus pallidus, substantia nigra, and cerebellum (Herkenham et al., 1991).”
BackgroundGordon, A. S., Collier, K., & Diamond, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2105 · Cited by 188
Cited by
Wang, L., Liu, J., Harvey-White, J., Zimmer, A., & Kunos, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336351100 · Cited by 340
Hungund, B. L., Szakall, I., Adam, A., Basavarajappa, B. S., & Vadasz, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01576.x · Cited by 334
Self-citationCannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll, B., & Goldberg, S. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 291
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
“Moreover, high alcohol preference and excessive alcohol intake are associated with altered expression and function of CB1 receptors and fatty acid amidohydrolase, a primary enzyme responsible for eCB degradation (Basavarajappa and Hungund, 2001; Hansson et al., 2007).”
BackgroundGonzález, S., Valenti, M., de Miguel, R., Fezza, F., Fernández‐Ruiz, J., Di Marzo, V., & Ramos, J. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705963 · Cited by 79
Metadata
- Authors
- Basavarajappa, B. S., & Hungund, B. L.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2001-04-30
- Volume
- 64
- Issue
- 4
- Pages
- 429-436
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2037711038
- Cited by
- 46
- References
- 2
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.